Position in NBIX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,539
+$773 QoQ
Shares Held
21
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#718
of 768 holders
Holding Since
Jun 2024
4 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $6,044,677 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBH |
Prestige Consumer Healthcare Inc.
|
75,121 | $3,550,969 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
60,364 | $2,045,132 | |
| 3 | ZTS |
Zoetis Inc.
|
5,616 | $403,564 | |
| 4 | VTRS |
Viatris Inc
|
1,189 | $18,881 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
148 | $16,419 | |
| 6 | HLN |
Haleon plc
|
441 | $4,113 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
21 | $3,539 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
|
44 | $643 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,539 | 21 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,766 | 21 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,836 | 20 | Shares | Sole | 2026-01-27 | |
| 2024-06-30 | $10,600 | 77 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||